HUIZENGA THEODORE ALAN (SVP, Chief Accounting Officer) sold 0.2% of their position (91.00 shares) of ULTRAGENYX PHARMACEUTICAL INC. on the open market
Open‑market sale worth $5.1K — a minor trim. Review remaining holdings and any 10b5‑1 plan disclosures.
S · 1 sale
Filed: 9/5/2024ACC: 0000950170-24-103807
Officer· SVP, Chief Accounting Officer
Since Mar 2026
-91.00
Net shares
Net seller
$5.1K
Total sold
1
Open market trades
0B · 1S
1
Total transactions
91.00 disposed
Non-Derivative Transactions1
Common Stock
Direct
Shares
−91.00
Price / share
$56.19
Trade value
$5.11K
% of position
0.2%
9/3/2024
41.64K→41.55K
Total
Net shares
−91.00
Net value
-$5.11K
| Security | Date | Type | Shares | Price / Share | Trade Value | % of Position | Held Before | Held After |
|---|---|---|---|---|---|---|---|---|
| Common Stock Direct | 9/3/2024 | S · Sale | −91.00 | $56.19 | $5.11K | 0.2% | 41.64K | 41.55K |
| Total | −91.00 | -$5.11K | ||||||
Derivative Transactions0
No derivative transactions reported